You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Valneva and Pfizer report Lyme disease antibody data

Pfizer has reported antibody persistence data six months after the completion of a two to three-dose vaccination schedule.